Obesity in pregnancy: Problems and potential solutions

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 2, 2011, Pages 442-452

  McKnight, Jason R ^a   Satterfield, M Carey ^a   Li, Xilong ^a   Gao, Haijun ^b   Wang, Junjun ^a,c   Li, Defa ^c   Wu, Guoyao ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adipocyte; Arginine; Brown Adipose Tissue; Metabolism; Nitric Oxide; Obesity; Review; Thermogenesis; Uncoupling Protein

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ARGININE; CITRULLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; AMINO ACID;

ARTICLE; BLOOD CLOTTING DISORDER; CALORIC RESTRICTION; CONGENITAL DISORDER; DEEP VEIN THROMBOSIS; DELIVERY; DIET SUPPLEMENTATION; DRUG EFFICACY; ENZYME ACTIVATION; FETUS DEATH; FETUS GROWTH; HUMAN; INSULIN RESISTANCE; KINESIOTHERAPY; LUNG COMPLICATION; MACROSOMIA; MATERNAL HYPERTENSION; MATERNAL OBESITY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PUERPERIUM; WEIGHT GAIN; WHITE ADIPOSE TISSUE; EXERCISE; FEMALE; FETUS DISTRESS; HYPERTENSION; METHODOLOGY; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VEIN THROMBOSIS;

ANIMALIA; MUS; OVIS ARIES; PAPIO; RATTUS; SUIDAE;

AMINO ACIDS; BLOOD COAGULATION DISORDERS; CALORIC RESTRICTION; DIETARY SUPPLEMENTS; EXERCISE; FEMALE; FETAL DISTRESS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; VENOUS THROMBOSIS;

EID: 79957805134     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e259     Document Type: Article

References (104)

1. Jobgen WS, Fried SK, Fu WJ, Meininger CJ & Wu G: Regulatory role for the arginine-nitric oxide pathway in energy-substrate metabolism. J Nutr Biochem 17, 571-588 (2006) (Pubitemid 44205442)
2. World Health Organization (WHO): Obesity: preventing and managing the global epidemic. Geneva (Switzerland): World Health Organization. WHO technical report series 894 (2009)
3. National Institute of Health (NIH) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 98-4083, Bethesda, MD, 1998
4. Abelson P & Kennedy D: The obesity epidemic. Science 304, 1413 (2004) (Pubitemid 38720893)
5. CDC: Obesity and Overweight for Professionals: Data and Statistics. http://www.cdc.gov/obesity/data/index.html. Accessed Nov 20, 2009
6. World Health Organization (WHO): World Health Statistics - 2009. www.who.int. Accessed March 2, 2010
7. Flegal KM, Carroll MD, Ogden CL & Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241 (2010)
8. Schrauwers C & Dekker G: Maternal and perinatal outcome in obese pregnant patients. J Maternal-Fetal Neonatal Med 3, 218-226 (2009)
9. Pi-Sunyer X: A clinical view of the obesity problem. Science 299, 859-860 (2003) (Pubitemid 36182436)
10. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J: Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090-101 (2010)
11. Beckett WS, Jacobs DR Jr, Yu X, Iribarren C & Williams OD: Asthma is associated with weight gain in females but not males, independent of physical activity. Am J Respir Critical Care Med 164, 2045-2050 (2001) (Pubitemid 34020246)
12. Flegal KM, Carroll MD, Kuczmarski RJ & Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22, 39-47 (1998) (Pubitemid 28036587)
13. Williamson DF, Kahn HS, Remington PL & Anda RF: The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med 150, 665-672 (1990) (Pubitemid 20122023)
14. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR & Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291, 2847-2850 (2004) (Pubitemid 38747805)
15. Abrams BF & Laros RK Jr: Prepregnancy weight, weight gain, and birth weight. Am J Obstet Gynecol 154, 503-509 (1986) (Pubitemid 16128009)
16. Naeye RL: Maternal body weight and pregnancy outcome. Am J Clin Nutr 52, 273-279 (1990)
17. Taffel SM, Keppel KG & Jones GK: Medical advice on maternal weight gain and actual weight gain. Results from the 1988 National Maternal and Infant Health Survey. Ann N Y Acad Sci 678, 293-305 (1993) (Pubitemid 23158910)
18. Siega-Riz AM, Adair LS & Hobel CJ: Institute of Medicine maternal weight gain recommendations and pregnancy outcome in a predominantly Hispanic population. Obstet Gynecol 84, 565-573 (1994) (Pubitemid 24311149)
19. Cogswell ME, Serdula MK, Hungerford DW & Yip R: Gestational weight gain among average-weight and overweight women - what is excessive? Am J Obstet Gynecol 172, 705-712 (1995)
20. Institute of Medicine. Nutritional status and weight gain. In: Nutrition during pregnancy. Washington, DC: National Academies Press; 1990. p. 27-233
21. Schieve LA, Cogswell ME & Scanlon KS: An empiric evaluation of the Institute of Medicine's pregnancy weight gain guidelines by race. Obstet Gynecol 91, 878-884 (1998) (Pubitemid 28246917)
22. Kiel DW, Dodson EA, Artal R, Boehmer TK & Leet TL: Gestational weight gain and pregnancy outcomes in obese women. Obstet Gynecol 110, 752-758 (2007) (Pubitemid 47508736)
23. Rode L, Hegaard HK, Kjaergaard H, Moller LF, Tabor A & Ottesen B: Association between maternal weight gain and birth weight. Obstet Gynecol 109, 1309-1315 (2007) (Pubitemid 46869869)
24. Shaikh H, Robinson S & Teoh TG: Management of maternal obesity prior to and during pregnancy. Sem Fetal Neonatal Med 15, 77-82 (2009)
25. Cedergren MI: Optimal Gestational Weight Gain for Body Mass Index Categories. Obstet Gynecol 110, 759-764 (2007) (Pubitemid 47508737)
26. Abrams B, Altman SL & Pickett KE: Pregnancy weight gain: still controversial. Am J Clin Nutr 71, 1233S-1241S (2000) (Pubitemid 30230523)
27. Stotland NE, Cheng YW, Hopkins LM & Caughey AB: Gestational weight gain and adverse neonatal outcome among term infants. Obstet Gynecol 108, 635-643 (2006) (Pubitemid 44337106)
28. DeVader SR, Neeley HL, Myles TD & Leet TL: Evaluation of gestational weight guidelines for women with normal prepregnancy body mass index. Obstet Gynecol 110, 745-751 (2007) (Pubitemid 47508735)
29. Vesco KK, Dietz PM, Rizzo J, Stevens VJ, Perrin NA, Bachman DJ, Callaghan WM, Bruce FC & Hornbrook MC: Excessive gestational weight gain and postpartum weight retention among obese women. Obstet Gynecol 114, 1069-1075 (2009)
30. Butte NF, Wong WW, Treuth MS, Ellis KJ & O'Brian SE: Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr 79, 1078-1087 (2004) (Pubitemid 41095961)
31. Kinoshita T & Itoh M: Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: the ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest 61, 115-118 (2006) (Pubitemid 43289485)
32. Ikeoka D, Mader JK & Pieber TR: Adipose Tissue, Inflammation and Cardiovascular Disease. Rev Assoc Med Bras 56, 116-121 (2010)
33. Galtier-Dereure F, Boegner C & Bringer J: Obesity and pregnancy: complications and cost. Am J Clin Nutr 71, 1242S-1248S (2000) (Pubitemid 30230524)
34. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M & Zinman B: C-reactive protein and gestational diabetes: The central role of maternal obesity. J Clin Endocrinol Metab 88, 3507-3512 (2003) (Pubitemid 37034486)
35. Roberts JM & Lain KY: Reent insights into the pathogenesis of pre-eclampsia. Placenta 23, 359-372 (2000)
36. Galtier F, Farret A & Bringer J. Grossesse et Obesite. In: Basdevant A, Guy-Grand B, editors. Medecine de l'Obesite. Paris: Flammarion Medecine Sciences; 2004. p. 347-350
37. Galtier F, Raingeard I, Renard E, Boulot P & Bringer J: Optimizing the outcome of pregnancy in obese women: From pregestational to long-term management. Diabetes & Metabolism 34, 19-25 (2008)
38. Bhattacharya S, Campbell DM, Liston WA & Bhattacharya S: Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 7, 168-175 (2007)
39. Poirier P, Giles T, Bray G, Hong Y, Stern J, Pi-Sunyer X & Eckel RH: Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Circulation 113, 898-918 (2006)
40. Wu G, Meininger CJ: Nitric oxide and vascular insulin resistance. BioFactors 35, 21-27 (2009)
41. Ramachenderan J, Bradford J & McLean M: Maternal obesity and pregnancy complications: A review. Aust N Z J Obstet Gynaecol 48, 228-235 (2008) (Pubitemid 351798367)
42. O'Brien TE, Ray JG & Chan WS: Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology 14, 368-374 (2003) (Pubitemid 40417091)
43. Eskenazi B, Fenster L & Sidney S: A multivariate analysis of risk factors for preeclampsia. JAMA 266, 237-241 (1991)
44. Baeten JM, Bukusi EA & Lambe M: Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91, 436-440 (2001) (Pubitemid 32179459)
45. Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Ovesen P & Beck-Nielsen H: Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol 189, 239-244 (2003) (Pubitemid 36886556)
46. Hall LF & Neubert A: Obesity and Pregnancy. Obstet Gynecol Survey 60, 8 (2005)
47. Hellgren M & Blomback M: Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 12, 141-154 (1981) (Pubitemid 11150978)
48. Greer IA: Haemostasis and thrombosis in pregnancy. In: Bloom AL, Forbes CD, Thomas DP, et al, editors. Haemostasis and Thrombosis in Pregnancy. Edinburgh (UK): Churchill Livingstone; p. 987-1015, 1994
49. Pien GW, Fife D, Pack AI, Nkwuo JE & Schwab RJ: Changes in symptoms of sleep-disordered breathing during pregnancy. Sleep 28, 1299-1305 (2005) (Pubitemid 41437891)
50. Callaway LK, Prins JB, Chang AM & McIntyre HD: The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust 184, 56-59 (2006) (Pubitemid 43174192)
51. Hendler I, Goldenberg RL, Mercer BM, Iams JD, Meis PJ, Moawad AH, MacPherson CA, Caritis SN, Miodovnik M, Menard KM, Thurnau GR & Sorokin Y: The Preterm Prediction Study: Association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 192, 882-886 (2005) (Pubitemid 40311284)
52. Brost BC, Goldenberg RL, Mercer BM, Iams JD, Meis PJ, Moawad AH, Newman RB, Miodovnik M, Caritis SN, Thurnau GR, Bottoms SF, Das A & McNellis D: The preterm prediction study: association of cesarean delivery with increases in maternal weight and body mass index. Am J Obstet Gynecol 177, 333-337 (1997)
53. Gore SA, Brown DM & West DS: The Role of postpartum weight retention in obesity among women: A review of the evidence. Ann Behav Med 26, 149-159 (2003) (Pubitemid 37271601)
54. Scholl TO, Hediger ML, Schall JI, Ances IG & Smith WK: Gestational weight gain, pregnancy outcome, and postpartum weight retention. Obstet Gynecol 86, 423-427 (1995)
55. Soltani H & Fraser RB: A longitudinal study of maternal anthropometric changes in normal weight, overweight and obese women during pregnancy and postpartum. Br J Nutr 84, 95-101 (2000) (Pubitemid 30611672)
56. Cedergren MI: Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103, 219-224 (2004)
57. Centre for Maternal and Child Enquiries (CAMCE): CAMCE -2008. www.camce.org.uk. Accessed March 2, 2010
58. Huang DY, Usher RH, Kramer MS, Yang H, Morin L & Fretts RC: Determinants of unexplained antepartum fetal deaths. Obstet Gynecol 95, 215-221 (2000) (Pubitemid 30045642)
59. Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB & Olsen J: Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 106, 250-259 (2005) (Pubitemid 41023260)
60. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L & Robinson S: Maternal obesity and pregnancy outcome: A study of 287,213 pregnancies in London. Int J Obes Relat Metabol Disord 25, 1175-1182 (2001) (Pubitemid 32721540)
61. Stotland NE, Caughey AB, Breed EM & Escobar GJ: Risk factors and obstetric complications associated with macrosomia. Int J Gynecol Obstet 87, 220-226 (2004) (Pubitemid 39535082)
62. Yogev Y & Catalano PM: Pregnancy and Obesity. Obstet Gynecol Clin N Am 36, 285-300 (2009)
63. Watkins ML, Rasmussen SA, Honein MA, Botto LD & Moore CA: Maternal obesity and risk for birth defects. Pediatrics 111, 1152-1158 (2003) (Pubitemid 36539220)
64. Berkowitz GS, Lapinski RH, Godbold JH, Dolgin SE & Holzman IR: Maternal and neonatal risk factors for cryptorchidism. Epidemiology 6, 127-131 (1995)
65. Kieser JA, Groeneveld HT & Da Silva PC: Dental asymmetry, maternal obesity, and smoking. Am J Phys Anthropol 102, 133-139 (1997) (Pubitemid 27074922)
66. Hendler I, Blackwell SC & Bujold E: The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures. Int J Obes 28, 1607-1611 (2004) (Pubitemid 39564341)
67. Wolfe HM, Sokol RJ, Martier SM, Zador IE: Maternal obesity: A potential source of error in sonographic prenatal diagnosis. Obstet Gynecol 76, 339-342 (1990) (Pubitemid 20264512)
68. Artal R, Catanzaro RB, Gavard JA, Mostello DJ & Friganza JC: A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Appl Physiol Nutr Metab 32, 596-601 (2007)
69. Knopp RH, Magee MS, Raisys V, Benedetti T, Bonet B: Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 10, 649-67 (1991)
70. Luke B, Hediger ML & Scholl TO: Point of diminishing returns: when does gestational weight gain cease benefiting birth weight and begin adding to maternal obesity? J Matern Fetal Med 5, 168-173 (1996)
71. Gavard JA & Artal R: Effect of exercise on pregnancy outcome. Clin Obstet Gynecol 51, 467-480 (2008) (Pubitemid 351655116)
72. Jovanovic-Peterson L & Peterson C: Is exercise safe or useful for gestational diabetic women? Diabetes 40, S179-S181 (1991)
73. Winder WW & Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. Am J Physiol Endocrinol Metab 277, E1-E10 (1999) (Pubitemid 29356721)
74. Song XM, Fiedler M, Galuska D, Ryder JW, Fernstrom M, Chibalin AV, Wallberg-Henriksson H & Zierath JR (2002) 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 45, 56-65. (Pubitemid 34118543)
75. Hardie DG, Scott JW, Pan DA, Hudson ER: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546, 113-120 (2003) (Pubitemid 36782291)
76. Gaidhu MP, Fediuc S, Anthony NM, So M, Mirpourian M, Perry RLS & Ceddia RB: Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 50, 704-715 (2009)
77. McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Meininger CJ, McNeal CJ & Wu G: Beneficial effects of L-arginine on reducing obesity: Potential mechanisms and important implications for human health. Amino Acids. DOI: 10.1007/s00726-010-0598-z (2010)
78. Wu G: Amino acids: metabolism, functions, and nutrition. Amino Acids 37, 1-17 (2009)
79. Li XL, Bazer FW, Gao H, Jobgen W, Johnson GA, Li P, McKnight JR, Satterfield MC, Spencer TE, Wu G: Amino acids and gaseous signaling. Amino Acids 37, 65-78 (2009)
80. Tan BE, Li XG, Kong XF, Huang RL, Ruan Z, Yao K, Deng ZY, Xie MY, Shinzato I, Yin YL, Wu G: Dietary Larginine supplementation enhances the immune status in earlyweaned piglets. Amino Acids 37, 323-331 (2009)
81. Wu G, Bazer FW, Wallace JM, Spencer TE: Intrauterine growth retardation: Implications for the animal sciences. J Anim Sci 84, 2316-2337 (2006) (Pubitemid 44367856)
82. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM, Satterfield MC, Smith SB, Spencer TE, Yin YL: Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37, 153-168 (2009)
83. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, Carroll RJ, Meininger CJ & Wu G: Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 135, 714-721 (2005) (Pubitemid 40464093)
84. Wu G, Collins JK, Perkins-Veazie P, Siddiq M, Dolan KD, Kelly KA, Heaps CL & Meininger CJ: Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr 137, 2680-2685 (2007) (Pubitemid 350255297)
85. Jobgen WJ, Meininger CJ, Jobgen SC, Li P, Lee MJ, Smith SB, Spencer TE, Fried SK, Wu G: Dietary L-arginine supplementation reduces white-fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr 139, 230-237 (2009)
86. Jobgen W, Fu WJ, Gao H, Li P, Meininger CJ, Smith SB, Spencer TE & Wu G: High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids 37, 187-198 (2009)
87. He QH, Kong XF, Wu G, Ren PP, Tang HR, Hao FH, Huang RL, Li TJ, Tan BE, Li P, Tang ZR, Yin YL, Wu YN: Metabolomic analysis of the response of growing pigs to dietary L-arginine supplementation. Amino Acids 37, 199-208 (2009)
88. Tan BE, Yin YL, Liu ZQ, Li XG, Xu HJ, Kong XF, Huang RL, Tang WJ, Shinzato I, Smith SB, Wu G: Dietary Larginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs. Amino Acids 37, 169-175 (2009)
89. Tan BE, Yin YL, Liu ZQ, Tang WJ, Xu HJ, Kong XF, Li XG, Yao K, Gu WT, Smith SB, Wu G: Dietary Larginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. J Nutr Biochem
90. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fremo I, Rabaiotti G, Gatti R & Piatti P: Beneficial effects of a long-term oral L-arginine added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 291, E906-912 (2006)
91. Rhoads JM, Wu G: Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 37, 111-122 (2009)
92. Tan BE, Yin YL, Kong XF, Li P, Li XL, Gao HJ, Li XG, Huang RL, Wu G: L-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells. Amino Acids 38, 1227-1235 (2010)
93. Yao K, Yin YL, Chu WY, Liu ZQ, Deng D, Li TJ, Huang RL, Zhang JS, Tan BE, Wang W, Wu G: Dietary arginine supplementation increases mTOR signaling activity in skeletal muscle of neonatal pigs. J Nutr 138, 867-872 (2008) (Pubitemid 351571584)
94. Nall JL, Wu G, Kim KH, Choi CW, Smith SB (2009) Dietary supplementation of L-arginine and conjugated linoleic acid reduces retroperitoneal fat mass and increases lean body mass in rats. J Nutr 139:1279-1285.
95. Lassala A, Bazer FW, Cudd TA, Li P, Li XL, Satterfield MC, Spencer TE, Wu G: Intravenous administration of L-citrulline to pregnant ewes is more effective than L-arginine for increasing arginine availability in the fetus. J Nutr 139, 660-665 (2009)
96. Mateo RD, Wu G, Bazer FW, Park JC, Shinzato I, Kim SW (2007) Dietary L-arginine supplementation enhances the reproductive performance of gilts. J Nutr 137:652-656 (Pubitemid 46397498)
97. Wu G, Bazer FW, Cudd TA, Jobgen WS, Kim SW, Lassala A, Li P, Matis JH, Meininger CJ, Spencer TE: Pharmacokinetics and safety of arginine supplementation in animals. J Nutr 137, 1673S-1680S (2007) (Pubitemid 46855529)
98. Gao HJ, Wu G, Spencer TE, Johnson GA, Li XL, Bazer FW: Select nutrients in the ovine uterine lumen: I. Amino acids, glucose and ions in uterine lumenal flushings of cyclic and pregnant ewes. Biol Reprod 80, 86-93 (2009)
99. Lassala A, Bazer FW, Cudd TA, Li P, Li XL, Satterfield MC, Spencer TE, Wu G: Intravenous administration of L-citrulline to pregnant ewes is more effective than L-arginine for increasing arginine availability in the fetus. J Nutr 139, 660-665 (2009)
100. Satterfield MC, Bazer FW, Spencer TE, Wu G: Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction. J Nutr 140, 251-258 (2010)
101. Reynolds LP, Caton JS, Redmer DA, Grazul-Bilska AT, Vonnahme KA, Borowicz PB, Luther JS, Wallace JM, Wu G & Spencer TE: Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol 572, 51-58 (2006)
102. Wang J, Ma H, Tong C, Zhang H, Lawlis GB, Li Y, Zang M, Ren J, Nijland MJ, Ford SP, Nathanielsz PW & Li J: Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J 24, 2066-76 (2010)
103. Li XL, Bazer FW, Johnson GA, Burghardt RC, Erikson DW, Frank JW, Spencer TE, Shinzato I, Wu G: Dietary supplementation with 0.8% L-arginine between days 0 and 25 of gestation reduces litter size in gilts. J Nutr 140, 1111-1116 (2010)
104. Schlabritz-Loutsevitch N, Farley D, Tejero ME, Comuzzie AG, Higgins PB, Cox L, Werner SL, Jenkins SL, Li C, Choj J, Dick EJ Jr, Hubbard GB, Frost P, Dudley DD, Wu G, Nathanielsz PW: Feto-placental adaptations to maternal obesity in the baboon. Placenta 30, 752-760 (2009)